Medpace Holdings
MEDP· Services· Fiscal year ends in December
August J. Troendle is the CEO of Medpace Holdings and was paid $11.4M in FY2025 (Dec), up 33%.
Executives5
See all- 1August J. TroendleChief Executive OfficerFY2025
- 2Susan E. BurwigExecutive Vice President, OperationsFY2025
- 3Jesse J. GeigerPresidentFY2025
- 4Stephen P. EwaldGeneral Counsel and Corporate SecretaryFY2025
- 5Kevin M. BradyChief Financial Officer and TreasurerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMedpace Holdings paid its 5 named executives $20.2M in total in FY2025 (Dec). CEO August J. Troendle was paid $11.4M of that.
| Name | |||
|---|---|---|---|
| August J. TroendleChief Executive Officer | |||
| Susan E. BurwigExecutive Vice President, Operations | |||
| Jesse J. GeigerPresident | Not disclosed | ||
| Stephen P. EwaldGeneral Counsel and Corporate Secretary | Not disclosed | ||
| Kevin M. BradyChief Financial Officer and Treasurer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers12
See allThe FY2024 (Dec) proxy of Medpace Holdings names 12 peer companies for pay. Among Medpace Holdings and these peers, CEO pay was 4th highest of 5 and total shareholder return was the highest of 5.
4th highest of 5in Medpace Holdings and its pay peers, FY2024 (Dec) by CEO pay:
1st highest of 5in Medpace Holdings and its pay peers, FY2024 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- Fred B. Davenport, Jr.Lead independent director · 6 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Governance—Paid as an executive
- Robert O. KraftDirector · 8 yr on the boardIndependentAudit, Compensation, Nominating and Governance—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 1, 2026 | FY2025 |
| Annual report | 10-K | Feb 10, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 2, 2025 | FY2024 |
| Annual report | 10-K | Feb 11, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 3, 2024 | FY2023 |
| Annual report | 10-K | Feb 13, 2024 | FY2023 |
